Ethris – Ethris

About Ethris

This author has not yet filled in any details.
So far Ethris has created 11 blog entries.

Ethris and Partners Receive Horizon 2020 Grant to Explore New Therapeutic Paradigm in Cardiac Regeneration

Ethris2020-02-11T08:58:41+01:00October 30th, 2019|

Ethris and Partners Receive Eurostars Grant for the Development of New mRNA Therapeutics for Osteoarthritis

Ethris2019-10-10T12:37:47+01:00July 24th, 2019|

Ethris’ Collaborators at LMU München Children’s Hospital Publish Paper in Nature Nanotechnology

Ethris2019-10-10T12:35:43+01:00January 28th, 2019|

Efficient ex vivo delivery of chemically modified messenger RNA using lipofection and magnetofection.

Ethris2017-02-13T12:06:51+01:00February 13th, 2017|

Modified mRNA for BMP-2 in Combination with Biomaterials Serves as a Transcript-Activated Matrix for Effectively Inducing Osteogenic Pathways in Stem Cells

Ethris2017-02-09T13:16:48+01:00February 9th, 2017|

Transcript-activated collagen matrix as sustained mRNA delivery system for bone regeneration

Ethris2017-02-13T11:36:40+01:00January 1st, 2017|

Stability analysis of chemically modified mRNA using micropattern-based single-cell arrays

Ethris2017-01-01T20:34:16+01:00January 1st, 2017|

Human cellular CYBA UTR sequences increase mRNA translation without affecting the half-life of recombinant RNA transcripts.

Ethris2017-01-01T20:34:06+01:00January 1st, 2017|

Chemically modified RNA induces osteogenesis of stem cells and human tissue explants as well as accelerates bone healing in rats

Ethris2017-02-13T11:54:37+01:00January 1st, 2017|

Single Methylene Group in Oligoalkylamine‐Based Cationic Polymers and Lipids Promotes Enhanced mRNA Delivery

Ethris2017-01-01T20:33:44+01:00January 1st, 2017|

Preclinical study with SNIM® RNA published in Nature Biotechnology

Ethris2017-02-09T13:02:36+01:00January 1st, 2017|